Completed
NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
NCT01521702
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- Institut Paoli Calmettes Marseille, France